Tamayo Louis Edward

Tamayo Louis Edward is listed in filings as Chief Financial Officer at Lexeo Therapeutics, Inc. Common Stock. This profile follows SEC Form 4 activity through Feb 6, 2026, including 4 public disclosures. Recent filings connect the profile to Lexeo Therapeutics, Inc. Common Stock (LXEO). The current snapshot covers public activity from Sep 3, 2025 to Feb 6, 2026. Reported amounts are shown as $1.6M to $1.3M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.